CCANED-CIPHERResearch EHR
Early Cancer Detection · Therapy Response

Integrated eSource, eConsent and EDC for blood-based early detection.

Sponsor: Dysplasia Diagnostics Limited · IRAS 350891 · NCT06717295. ICH GCP E6(R3) and MHRA GxP-aligned. AI-assisted operations, human-in-the-loop decisions, FHIR/UK-Core interoperable, with first-class sample chain-of-custody.

Observational · No individual AI biomarker results returned · Protocol v1.4
Sign in

Welcome back

Authenticate with your study credentials.

Google sign-in only works for pre-approved institutional accounts.

or email
ICH GCP E6(R3) MHRA GxP UK GDPR